Stock listing
gettex:S49 Supernus Pharmaceuticals, Inc. Aktie
German listing (gettex) of Supernus Pharmaceuticals, Inc. · home listing NASDAQ:SUPN
Follow Supernus Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:SUPN
$37.88 USD -1.69 (-4.3%)
Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:SUPN
- Day range
- $37.54 – $39.49 USDOct 16, 2026
- Volume
- 1.44M sharesOct 16, 2026
- Market value
- $2.21B USDAt the close on Oct 16, 2026 · price × 58.22M shares outstanding
- Ticker
- gettex:S49
- Asset type
- Stock
- Exchange
- gettex
- Currency
- EUR
What changed lately
Latest news release · Aug 31, 2026
Chloe Kim Teams Up with Qelbree®, the #1 Prescribed Branded Non-Stimulant ADHD Treatment*, to Help Empower People Navigating ADHD
Latest earnings call · Aug 4, 2026
Supernus Pharmaceuticals (NASDAQ:SUPN) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 3, 2026
Merger or Acquisition (August 2026)
Merger or acquisition · 11 slides
Calls
Replays
Supernus Pharmaceuticals (NASDAQ:SUPN) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 4:30 PM ET
Watch TranscriptSupernus Pharmaceuticals (NASDAQ:SUPN) Q1 2026 Earnings Call
Tue, May 05, 2026 · 4:30 PM ET
Watch TranscriptSupernus Pharmaceuticals (NASDAQ:SUPN) Q4 2025 Earnings Call
Tue, Feb 24, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Decks
Merger or Acquisition (August 2026)
Merger or acquisition · 11 slides · Aug 3, 2026
Merger or Acquisition (August 2026)
Merger or acquisition · 13 slides · Aug 3, 2026
Investor Presentation (May 2026)
Investor deck · 35 slides · May 2026
Merger or Acquisition (June 2025)
Merger or acquisition · 16 slides · Jun 16, 2025
Supernus Pharmaceuticals, Inc. on 6ix
- News releases
- 18 in the last 12 months · 156 in all · newest Aug 31, 2026 · oldest 2019
- Calls
- 24 calls with a replay · 24 with a transcript · latest Aug 4, 2026
- Decks
- 16 decks · latest Aug 3, 2026
Where Supernus Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:SUPN · Home listing | NASDAQ | United States | USD |
| Lang & Schwarz:A1JX3U | Lang & Schwarz | Germany | EUR |
| LS Exchange:A1JX3U | LS Exchange | Germany | EUR |
| gettex:S49 · This page | gettex | Germany | EUR |
| BOATS:SUPN | BOATS | United States | USD |
| LSE:0LB2 | LSE | United Kingdom | USD |
| Frankfurt:S49 | Frankfurt | Germany | EUR |
| BX Swiss:S49 | BX Swiss | Switzerland | CHF |
| Dusseldorf:S49 | Dusseldorf | Germany | EUR |
| Munich:S49 | Munich | Germany | EUR |
| Stuttgart:S49 | Stuttgart | Germany | EUR |
| Tradegate:S49 | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Supernus Pharmaceuticals, Inc.